✨ Health Notices




19 MARCH 2009 NEW ZEALAND GAZETTE, No. 35 941

Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Coldrex PE Phenylephrine Sinus
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg equivalent to 4.1mg phenylephrine
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Australia Pty Limited, Consumer Healthcare, Ermington, New South Wales, Australia

Product: Fludarabine Ebewe
Active Ingredient: Fludarabine phosphate 25mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturer: EBEWE Pharma GmbH Nfg KG, Unterach am Attersee, Austria

Product: Paracetamol (Medix)
Active Ingredient: Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: Nova Pharmaceuticals NZ Limited
Manufacturer: Marksans Pharma Limited, Verna, Goa, India

Product: Paracetamol (Home Brand)
Active Ingredient: Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: Nova Pharmaceuticals NZ Limited
Manufacturer: Marksans Pharma Limited, Verna, Goa, India

Dated this 13th day of March 2009.

ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go2496

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Baraclude
Active Ingredient: Entecavir monohydrate 0.05mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Company, Mt Vernon, Indiana, United States of America

Product: Baraclude
Active Ingredient: Entecavir monohydrate 0.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2009, No 35





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
13 March 2009
Medicines, Distribution, Consent, Paracetamol, Phenylephrine, Fludarabine
  • ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health

πŸ₯ Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
Medicines, Distribution, Consent, Baraclude, Entecavir